Corteva, Inc.
Q1 FY26 Earnings Call Analysis
Chemicals
fundraise: No informationcapex: Yesrevenue: Category 3margin: Category 3orderbook: Yes
💰fundraise
Any current/future new fundraising through debt or equity?
- No explicit mention of new fundraising through debt or equity in the provided transcript.
- The company aims for both new businesses post-separation to maintain investment-grade credit profiles.
- Board approved a $1.5 billion discretionary contribution to the U.S. pension plan to help position both companies for long-term success; this was funded from existing resources.
- Capital structures for the two separated companies are being finalized, targeting investment-grade leverage levels.
- No specific plans announced for issuing new debt or equity; focus is on strong balance sheets and credit metrics.
- Share repurchase plan remains in place with approximately $500 million planned in the first half of the year.
- Overall, current strategy emphasizes prudent capital allocation rather than raising new funds.
🏗️capex
Any current/future capex/capital investment/strategic investment?
- Expansion of biofuel crop development program globally with multiple partners.
- Growing sustainable aviation fuel crop acreage: ~100,000 acres harvested in the southern U.S. last fall, expanding to over 400,000 acres next year.
- Launching 50-50 JV with BP in Latin America to expand mustard crops, and starting canola and sunflower, with material planting expected in 2027.
- Investment in proprietary next-gen aboveground and belowground traits for Vylor (formerly Corteva Seed & Genetics), expected around 2030-2031.
- Continuing development and commercialization of at least 7 new active ingredients and biological products in Crop Protection over the next decade.
- $1.5 billion discretionary contribution to U.S. pension plan supporting capital structure setup for both standalone companies post spin-off.
- Strategic spend related to separation and setting up management and operational structures for new entities, including filing Form 10 and public listing preparations.
📊revenue
Future growth expectations in sales/revenue/volumes?
- Next-gen aboveground products launching in North America by 2030; Latin America will have both above and below ground products by 2030-2031.
- Pipeline includes at least 7 new active ingredients expected over the next decade.
- New products projected to push $2 billion in revenue this year, with growth continuing.
- Key future blockbusters include Avisa in Latin America, plus upcoming biologicals enhancing farm gate value.
- Crop Protection volume growth expected mainly from Latin America in the second half of the year, driven by more acres planted and expanding biological portfolio.
- Seed volumes up 6% in Q1 with strong early-season deliveries; price mix improving low to mid-single digits in second half.
- Crop Protection volumes up 6% with new products and spinosyn driving double-digit growth.
- Biofuel crop program expanding acreage significantly next few years, supporting long-term growth.
- Overall, moderate organic growth expected with Crop Protection industry projected to grow low single digits in 2026.
📈margin
Future growth expectations in earnings/operating earnings/profits/EPS?
- Full year 2026 guidance reaffirmed:
- Operating EBITDA expected between $4.0B to $4.2B
- Operating EBITDA margin forecasted at 22% to 23%
- Operating EPS projected in the range of $3.45 to $3.70, representing ~7% growth at midpoint
- Strong Q1 2026 performance with 21% increase in EBITDA and 240 basis points margin expansion
- Continued organic growth supported by price mix, volume gains, and cost savings
- Expect modest industry growth in crop protection low single digits in 2026 with positive signs into 2027
- New products pipeline expected to drive growth, including 7 new active ingredients and biologicals in crop protection
- Seed business becoming royalty positive this year, supported by $1B+ incremental revenue from out-licensing and hybrid wheat program
- Productivity initiatives and cost discipline contributing to margin expansion and free cash flow conversion in line with midterm targets
📋orderbook
Current/ Expected Orderbook/ Pending Orders?
- The order book currently reflects expectations of increased corn acreage in the U.S., indicating strong demand (Page 8).
- Latin America is a key driver for second-half volume growth, with more acres planted and growing demand for biologicals such as Nutricia and Blue (Page 11).
- Crop Protection volumes forecast to grow from single digits in the first half to high single digits in the second half, primarily driven by Latin America (Page 11).
- Strong demand exists for corn and soybean technology, supported by Bayer agreement, contributing about $1 billion in royalty revenue growth over the next decade (Page 5).
- Biologicals and new product launches expected to contribute meaningfully to order growth in the second half, especially in Latin America (Page 4).
